BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3463012)

  • 1. [Pharmacology and pharmacodynamics of various antitumor medications and the development of new treatment protocols].
    Haanen C
    Verh K Acad Geneeskd Belg; 1986; 48(2):65-83. PubMed ID: 3463012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blast self-renewal capacity as a target of the treatment in acute myelocytic leukemia].
    Nara N
    Rinsho Ketsueki; 1994 Jan; 35(1):1-8. PubMed ID: 8139096
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
    Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F
    Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is the cure of acute myeloblastic leukemia in the adult possible?].
    Ribas-Mundó M
    Med Clin (Barc); 1984 Dec; 83(19):800-3. PubMed ID: 6396459
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental and clinical use of cell cultures in chronic myeloid leukemia].
    Burgaleta C; Soria H; Moreno T
    Sangre (Barc); 1984; 29(4-B):549-64. PubMed ID: 6393382
    [No Abstract]   [Full Text] [Related]  

  • 6. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Karp JE; Ross DD; Yang W; Tidwell ML; Wei Y; Greer J; Mann DL; Nakanishi T; Wright JJ; Colevas AD
    Clin Cancer Res; 2003 Jan; 9(1):307-15. PubMed ID: 12538483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal liver infusion: an adjuvant in the therapy of acute myeloid leukemia (AML).
    Kochupillai V; Sharma S; Francis S; Mehra NK; Nanu A; Verma IC; Takkar D; Kumar S; Gokhale U
    Prog Clin Biol Res; 1985; 193():267-79. PubMed ID: 3911212
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical studies on combined chemotherapy of leukemia with partial cell synchronization].
    Büchner T; Asseburg U; Kamanabroo D; Hiddemann W; Hiddemann RM; Barlogie B; Göhde W
    Verh Dtsch Ges Inn Med; 1974; 80():1674-8. PubMed ID: 4532883
    [No Abstract]   [Full Text] [Related]  

  • 9. Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience.
    Khouri IF; Kantarjian HM; Talpaz M; Giralt S; Rios MO; Hester JP; Champlin RE; Deisseroth AB
    Bone Marrow Transplant; 1996 May; 17(5):775-9. PubMed ID: 8733697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticancer drug sensitivity tested by tumor stem cell assay].
    Hiraki S; Ohnoshi T; Miyai M; Numata T; Kishimoto N; Miyamoto H; Kimura I
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1139-45. PubMed ID: 6471420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of the combined antileukemic therapy with various agents on the ultrastructure of the bone marrow cells of patients with myelogeous leukemia].
    Nagao T; Sakamoto T; Saito K; Kitajima K
    Igaku To Seibutsugaku; 1969 Oct; 79(4):167-9. PubMed ID: 5260431
    [No Abstract]   [Full Text] [Related]  

  • 13. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acute myeloid leukemia with an intense chemotherapeutic regimen and variable reduction of the dosage for elderly patients].
    Whittaker JA
    Clin Ter; 1982 Sep; 102(5):435-41. PubMed ID: 6960975
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ambulatory period of treatment of adults with acute leukemia].
    Vinogradova IuE; Korovina VI
    Ter Arkh; 1981; 53(9):14-20. PubMed ID: 6458111
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukemia: A model for drug development.
    Keating MJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2598-604. PubMed ID: 9815664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemosensitivity testing for human ovarian cancer on in vitro colony assay].
    Inoue K
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1146-51. PubMed ID: 6471421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [10 years' therapy of acute leukemias].
    Schaefer UW
    Onkologie; 1986 Oct; 9 Suppl 2():30, 32-3. PubMed ID: 3534672
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progresses in the therapy of acute leukemia in the adult].
    Gunz FW; Vincent PC; Levi JA
    Clin Ter; 1972 Mar; 60(5):401-14. PubMed ID: 4504612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.